Is Getting 100% Of Employees Back To The Office Realistic? 3 Biopharma Execs Discuss

Source: Life Science Leader

In this executive virtual roundtable (EVR) segment, Britt Byers, SVP of human resources for Kyowa Kirin North America; Scott Nogi, VP of business operations for Abeona Therapeutics; and James Mackay, PhD, founder, president, and CEO of Aristea Therapeutics, share thoughts and opinions on companies that are gearing up to have 100% of their employees returning to in-office operations in September.